FDA makes flu vaccine recommendations after canceled VRBPAC, closed-door meeting
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesRegulatory Intelligence/PolicyUnited StatesRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesRegulatory Intelligence/PolicyUnited States